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ABSTRACT
Aptamer-based assays are a powerful platform for sensing a wide variety of
biochemical targets, including drugs, disease biomarker, and biomolecules.
However, aptamer assays often lack rapid identification and high-throughput
screening. Performing an aptamer-based assay on a microfluidic device is a
promising solution to increase throughput, portability, and sensitivity. In this paper,
we present a microfluidic device capable of running aptamer-based assays. Our
device utilizes normally-closed valves and a central micropump to move fluids
throughout the chip. One chip could theoretically be scaled up to run multiple
assays, and multiple of these microfluidic devices could be run in parallel to
increase throughput. Our experiments characterized the actuation pressure needed
to normally-closed valves with different size parameters, showed and characterized
flow using both oil and water solutions, and demonstrated modular movement on a
chip with six micropumps. Lastly, we designed a cartridge topper system to
eliminate the need for pins leading to a pneumatic controller so chips could easily
be switched out. By demonstrating flow and mixing, our chip is fully capable of
running an aptamer-based assay.
Keywords: Flow-Based Microfluidics, Assay Platform, Aptamer-Based Assays.

i

Acknowledgements
This thesis is dedicated to our families and loved ones. During the last year of work, they showed
continued support and excitement that motivated us in the completion of this project.
Our faculty advisors Dr. Emre Araci and Dr. Steven Suljak were integral to our success. They
guided us in overcoming challenges and complications throughout the project. They gratefully
shared their laboratory resources and knowledge over the past year. Additionally, we owe great
thanks to Shaun Synder, Daniel Levy, and Daryn Baker; as lab managers, they provided us with
the space, training, and resources needed to carry out our experiments.
We would also like to thank Santa Clara University and The School of Engineering for their
financial support that allowed us to carry out this research.

ii

Table of Contents
Page
1. Introduction ................................................................................................................................. 1
1.1 Significance................................................................................................................... 1
1.2 Statement of Project Objectives .................................................................................... 1
1.3 Review of Field and Related Literature ........................................................................ 1
1.3.1 Aptamer Overview ......................................................................................... 1
1.3.2 Aptamer-Based Assay .................................................................................... 3
1.3.3 Microfluidics .................................................................................................. 5
1.3.4 Microfluidic Aptamer Assays ........................................................................ 7
1.4 Back-up Plan ................................................................................................................. 8
1.5 Significance................................................................................................................... 9
2. Details of Key Constraints ........................................................................................................ 10
2.1 Critiques of Existing Technologies ............................................................................. 10
2.2 Analysis of Key Constraints ....................................................................................... 10
3. Detailed Design Description ..................................................................................................... 12
3.1 First-Generation Chips ................................................................................................ 12
3.1.1 Actuation Pressure Tests .............................................................................. 12
3.1.2 Flow Tests .................................................................................................... 13
3.2 Second-Generation Chips ........................................................................................... 15
3.2.1 Changing Flow Channel Heights ................................................................. 15
3.2.2 Changing Control Channel Heights ............................................................. 15
3.3 Cartridge-Topper......................................................................................................... 15
4. Expected Results ....................................................................................................................... 17
5. Materials and Methods.............................................................................................................. 18
5.1 Microfluidic Chip Fabrication .................................................................................... 18
5.1.1 Photolithography Process............................................................................. 18
5.1.2 Soft Lithography Process ............................................................................. 19
5.2 Microfluidic Testing Protocol ..................................................................................... 19
5.3 Flow Rate Calculations ............................................................................................... 20
5.4 Cartridge Topper ......................................................................................................... 20
iii

6. Results ....................................................................................................................................... 21
6.1 Normally-Closed Valve Characterization ................................................................... 21
6.2 Flow Demonstration with Oil ..................................................................................... 24
6.2.1 Oil Flow on Chips with 100 µm Tall Flow Channels and 50 µm Tall Control
Channels................................................................................................................ 24
6.2.2 Oil Flow on Chips with 100 µm Tall Flow Channels and 100 µm Tall
Control Channels .................................................................................................. 26
6.3 Mixing Demonstration Using Oil ............................................................................... 27
6.3.1 Mixing Oils on Chips with 100 µm Tall Flow Channels and 50 µm Tall
Control Channels .................................................................................................. 27
6.3.2 Mixing Oils on Chips with 100 µm Tall Flow Channels and 100 µm Tall
Control Channels .................................................................................................. 28
6.4 Modular Chip Demonstration Using Oil..................................................................... 29
6.5 Mixing and Flow Using Water-Based Solutions ........................................................ 30
6.5.1 Water Flow on Chips with 100 µm Tall Flow Channels and 100 µm Tall
Control Channels .................................................................................................. 30
6.5.2 Mixing Water-Based Solutions on Chips with 100 µm Tall Flow Channels
and 100 µm Tall Control Channels ....................................................................... 31
6.6 Actuation Using the Cartridge-Topper ....................................................................... 32
7. Discussion ................................................................................................................................. 34
7.1 Normally-Closed Valve Characterization ................................................................... 34
7.2 Characterization of the Microfluidic Platform ............................................................ 35
7.3 Cartridge-Topper......................................................................................................... 36
7.4 Future Work ................................................................................................................ 36
8. Engineering Standards and Realistic Constraints ..................................................................... 38
8.1 Ethical ......................................................................................................................... 38
8.2 Science, Technology, and Society and Civic Engagement ......................................... 38
8.3 Economic .................................................................................................................... 38
8.4 Health and Safety ........................................................................................................ 39
8.5 Manufacturability and Usability ................................................................................. 39
8.6 Sustainability and Environmental Impact ................................................................... 39
iv

APPENDIX ................................................................................................................................... 41
Appendix A-1: References ................................................................................................ 41
Appendix A-2: Gantt Chart............................................................................................... 44

v

LIST of FIGURES
Page
Figure 1-1: Aptamer sequence dictates 3D structure formation which dictates target binding to a
variety of biomarkers. ........................................................................................................................ 2
Figure 1-2: Capillary electrophoresis SELEX process for isolating aptamers specific for a
biomarker. .......................................................................................................................................... 3
Figure 1-3: Different aptamer-based assay set-ups. ......................................................................... 5
Figure 1-4: The standard layout of a flow-based microfluidic system............................................. 6
Figure 1-5: Functions of normally-open and -closed valves. ........................................................... 7
Figure 1-6: A schematic of a microfluidic device with a central micropump. ................................. 8
Fluids are added or removed in the input/output holes and pulled into the central micropump using
sequential valve actuation.................................................................................................................. 8
Figure 3-1: An array of normally closed valves with consistent control channel valve widths of
700 µm. ............................................................................................................................................ 13
Figure 3-2: An array of normally closed valves with control channel valve widths increasing in
200 µm increments. ......................................................................................................................... 13
Figure 3-3: Normally-closed valve flow schematic. ...................................................................... 14
Figure 3-4: A pump test array. ....................................................................................................... 14
Figure 3-5: The cartridge topper schematic. .................................................................................. 16
Figure 6-1: The three parameters varied in actuation pressure tests. ............................................. 21
Figure 6-2: Negative pressure of actuation for NCVs with increasing channel widths. ................ 22
Figure 6-3: Negative pressure of actuation for NCVs with increasing gap widths. ....................... 23
Figure 6-4: Negative pressure of actuation for NCVs with increasing valve widths. .................... 24
Figure 6-5: Sequential flow through a three-input 100 µm tall flow and 50 µm tall control
channels chip. .................................................................................................................................. 25
Figure 6-6: Actuation of the 100 µm tall flow channel and 50 µm tall control channel
micropumps. .................................................................................................................................... 26
Figure 6-7: Flow through the 100 µm tall flow and 100 µm tall control channel chip with oil. ... 27
Figure 6-8: Sequential mixing in a three-input chip....................................................................... 28
Figure 6-9: Sequential mixing in a 100 µm tall flow and 100 µm tall control channel chip with oil.29
Figure 6-10: Sequential mixing in a three-input chip..................................................................... 30
Figure 6-11: Flow through the 100 µm tall flow channel and 100 µm tall control channel
micropump using water. .................................................................................................................. 31
Figure 6-12: Sequential mixing in a 100 µm tall flow and 100 µm tall control channel chip with
water. ............................................................................................................................................... 32
Figure 6-13: The cartridge topper with a microfluidic chip. .......................................................... 33

vi

LIST of TABLES
Page
Table 5-1: Conditions tested to obtain various mold heights. ........................................................ 18
Table 5-2: Conditions tested to obtain various control and flow channel heights. ........................ 19

vii

1. Introduction
1.1 Significance
In recent years, aptamer-based assays have been developed for the screening of various
diseases.1 Aptamers, compromised of single strands of DNA or RNA, exhibit high affinity and
selectivity to a variety of biomolecular targets. Aptamers offer an alternative to antibodies in
diagnostic assays and have several advantages, including lower cost, ease of chemical
modification, and a smaller size. Although aptamer research shows a lot of promise, current
aptamer assays lack the rapid identification and ease of high throughput screening.2 The ability
to run aptamer assays on microfluidic chips provides a robust and efficient solution to this.
Microfluidic chips manipulate fluids on the micro- to nano-scale.3 The chips can be automated
and scaled-up. The objective of the project is to design a high-throughput and portable
microfluidic device to run antibody-aptamer hybrid ELISA assay to test the binding of aptamers
to a variety of peptide constructs.
1.2 Statement of Project Objectives
Our project has three main objectives:
1. Create a microfluidic system utilizing normally-closed valves, allowing increased
portability, and micropumps, allowing fluids to be moved throughout the chip and mixed.
2. Characterize the actuation pressure of different normally-closed valves and determine the
pumping rates of different sized micropumps.
3. Develop a protocol to run an aptamer-based assay on the microfluidic chip.

1.3 Review of Field and Related Literature
1.3.1 Aptamer Overview
Aptamers are short, single strands of oligonucleotides, either DNA or RNA, that can have high
affinity and specificity for a certain target. Affinity refers to how strong aptamers will bind to
their targets, and specificity refers to the ability of the aptamers to bind to the target over other
similar biomolecules. Due to the inherent base-pairing properties of DNA, aptamers will form
1

unique three-dimensional structures (Figure 1-1).4 These structures give aptamers their ability to
bind to a wide range of biomolecular targets.

Figure 1-1: Aptamer sequence dictates 3D structure formation which dictates target binding to a variety of
biomarkers. Source: Sun, et al.4

Aptamers are commonly evolved through the systematic evolution of ligands by exponential
enrichment (SELEX) process (Figure 1-2).5 The SELEX process starts with a large pool of
random DNA sequences, ranging from 1010-1014 sequences. The sequences are incubated with
the biomolecular target of interest, where strands with higher affinity for the target will bind to
the target. The bound oligonucleotides are separated from the unbound oligonucleotides using
various techniques including filter binding assays and capillary electrophoresis.6These bound
oligonucleotides are then separated from the biomolecular target and are amplified using
polymerase chain reaction (PCR), creating a narrower, more selective DNA pool. After several
rounds of incubating the isolated DNA pool with the target of interest, the resulting aptamers will
have a higher affinity for the target. To obtain high selectivity, the DNA pool can be incubated
with a biomolecule similar to the target of interest. In these counter-selection rounds, the
aptamers that do not bind to the molecule are selected for further amplification by PCR.

2

Figure 1-2: Capillary electrophoresis SELEX process for isolating aptamers specific for a biomarker. After
isolation, these aptamers can be translated into aptamer-based assays.

Traditionally, antibodies have been used in assays due to their high affinity and specificity for a
wide range of biomolecular targets, including cocaine,7 dopamine,8 Zika virus,9 and HIV reverse
transcriptase.10 Aptamers offer several advantages over antibodies, including 1) smaller size and
the ability to bind to a wider variety of targets, 2) a structure that is more readily chemically
modifiable and compatible with a variety of functional groups, 3) cheaper and easier production
due to the ease of DNA synthesis, and 4) stability at higher temperatures.1 Because functional
groups can be inserted on aptamers, aptamers can be readily conjugated to a variety of surfaces,
which is key in aptamer-based assays.
1.3.2 Aptamer-Based Assay
Assays are used in a variety of fields to assess the presence of a certain molecule, biomolecule,
organism, or biomarkers within a specific sample. Aptamer-based assays include a variety of
techniques. Aptamer assays are composed of a capture agent, often fixed to a surface, that has
high affinity and selectivity for the target that binds to the target, and a reporter agent, often in
free solution, which gives a measurable signal, such as fluorescence. Aptamers can function as
the capture agent, the reporter agent, or both. They can be fixed to plates as shown by Lee et al.,9
attached to microspheres as shown by Lin et al.,11 or attached to magnetic beads as shown by Li
3

et al.12 Some aptamer-based assays will also include antibodies and function as a hybrid assay.
All of these assays analyze a liquid sample, often human serum, to detect a biomolecular target.
Most high-throughput biomolecule assays are based on a sandwich format, such as the common
enzyme-linked immunosorbent assays (ELISA). One approach to aptamer-based assays utilizes a
sandwich assay.12 This includes a capture aptamer fixed to a surface and a reporter aptamer in
free solution (Figure 1-3A). When the serum is added, the capture aptamer binds its target. The
rest of the serum is washed away, and the reporter aptamer is added. The reporter aptamer binds
to the target molecule on a different spot than the detector and emits a detectable signal such as
radioactivity or fluorescence. The intensity of the signal is correlated to the concentration of the
target molecule.
Enzyme-linked aptamer assays (ELAA) use enzymes to catalyze a measurable signal.7,12,13 These
enzymes are often linked onto the reporter aptamer (Figure 1-3B). Horseradish peroxidase (HRP)
is a commonly used enzyme. When highly-conjugated ring molecules are added into the
solution, HRP in the presence of hydrogen peroxide will oxidize the molecules, leading to a
color shift. This color shift can be detected using spectrophotometric methods. When HRP is
conjugated to an aptamer that binds to a target, HRP activity will be decreased and the color shift
will be slowed. The color shift rate can be correlated to the concentration of the target molecule
in the solution.
Using aptamers in conjunction with antibodies is known as enzyme-linked apta-sorbent assays
(ELASA) (Figure 1-3C).1,9 There are many different configurations for ELASA, including using
the aptamer as the capture or the reporter aptamer.

4

Figure 1-3: Different aptamer-based assay set-ups. A) Two aptamers in the sandwich configuration. The signal
element on the reporter aptamer could be a fluorescent or radioactive signal. B) Two aptamers in the ELAA
configuration. The reporter aptamer is conjugated with an enzyme, which catalyzes a color shift in the solution. C)
An aptamer and an antibody in the ELASA configuration. The system uses a capture antibody and a reporter
aptamer with an enzyme.

1.3.3 Microfluidics
Microfluidics is the manipulation of fluids ranging in volume from microliters to picoliters
allowing a significant reduction in the reagent volume needed in experiments, which decreases
cost and produced waste.14 The field of microfluidics contains many different techniques and
technologies, including flow-based,3 droplet-based,15 paper,16 and electrowetting microfluidics.17
We aim to work within the flow-based microfluidic area. Flow-based microfluidic systems have
several advantages over other microfluidic techniques, including: 1) generating higher
throughput, 2) allowing easy experimental automation, and 3) creating higher robustness.
Flow-based microfluidic devices are traditionally made of an elastic, inert polymer, such as
polydimethylsiloxane (PDMS), and contain a flow and a control layer (Figure 1-4).3 The liquid
or aqueous solution is passed through the flow layer using external pressure or on-chip pumping
mechanism. The control layer uses pneumatic valves to stop flow through the flow layer. Many
5

microfluidic devices utilize normally-open valves, where the flow channels are open when no
pressure is applied to the control channel (Figure 1-5A).18 Normally-closed valves (NCVs) are
closed when no pressure is applied to the control channels and are typically opened by applying a
vacuum pressure in the control channel (Figure 1-5B).19. Normally-closed valves allow a
microfluidic device to be detached from pneumatic controllers and be moved while the liquids
stay in the same chambers on the chip. This portability is important for assay steps which may
need to be performed at a range of temperatures.

Figure 1-4: The standard layout of a flow-based microfluidic system. Panel A shows the system with no pneumatic
control applied, and Panel B shows the system with a metal pin leading to a pneumatic control.

6

Figure 1-5: Functions of normally-open and -closed valves. The arrow indicates the direction of flow when the
channel is open. Panel A shows a normally-open valve before and after a positive pressure is applied to the control
channel. Panel B shows a normally-closed valve before and after a negative pressure is applied to the control
channel.

1.3.4 Microfluidic Aptamer Assays
Aptamer assays have been translated to microfluidic assays. Microfluidic assays use lower
reagent volumes and tend to be faster than traditional assays.20–22 A study from a group at the
University of Santa Barbara attempted to develop a platform that performed magnetic beadassisted SELEX on a microfluidic scale in order to successfully isolate aptamers after the first
round of selection.23 The microfluidic device used microfabricated nickel ferromagnetic
structures. Isolating DNA aptamers that are bound to the light chain of recombinant Botulinum
neurotoxin type A, they were able to show the potential of the technology with a potent toxin,
emphasizing its therapeutic and biodefense applications. While no assay was performed on the
chip, the architecture of the chip theoretically allowed for an assay to be run on it.
A research collaboration between the National Tsing Hua University, Taiwan, and the National
Cheng Kung University, Taiwan, created a microfluidic aptamer assay to detect glycated
hemoglobin.12 The dual aptamer assay decreased analysis time from 3.5 hrs to 30 min and
decreased the reagent volume by 75%. The assay established linear relationships between
glycated hemoglobin concentration and fluorescence intensity.
7

Several designs incorporate a central pump system within multiple input/output wells (Figure 16). One group utilized a microfluidic chip with a central pump to detect protein thrombin with an
aptamer sandwich assay.24 Magnets were used to fix magnetic beads to wells during different
steps. The pump was connected to an external pneumatic device to move the chips in and out.
This chip had a limit of detection (LOD) for thrombin of 10 ng/mL, which was an improvement
of the LOD of a well-plate assay of 18 ng/mL.
Another group later improved on this design by adding a central micropump. They designed a
microfluidic aptamer-assay for the detection of H1N1 virus (Figure 1-6).2 The microfluidic
device could be run in 30 min and had a comparable limit of detection to a traditional dualantibody assay, 0.032 and 0.031hemagglutination units respectively. The device utilized
normally-closed valves and a central micropump, actuated along with the valves using an
external pneumatic source with lines leading to the chip, to control the movement of liquid
throughout the chip. Aptamers were conjugated to magnetic beads, which were fixed in
chambers for washing steps using a magnet.

Figure 1-6: A schematic of a microfluidic device with a central micropump. Fluids are added or removed in the
input/output holes and pulled into the central micropump using sequential valve actuation.

1.4 Back-up Plan
Our current design relies on normally-closed valves for its portability. If the normally-closed
valves fail to function properly, normally-open valves could be utilized. The chip could still be
8

used to perform an assay, but the preparation steps would need to be performed off-chip as the
chip would no longer be portable.
If the micropumps fail to work, the liquid could be moved into the chips using an external
pressure. However, this would require more set-up; our design intends to have open holes that
liquids can be pipetted into. With a fluid under pressure, the fluid would need to be placed in a
device that could apply constant pressure or flow.
1.5 Significance
We are developing a microfluidic chip that others will be able to use for the rapid screening of
various diseases. Our design allows aptamer assays to run with higher efficacy and speed than
traditional assay systems, all at a lower cost. As aptamers have high binding affinities and
specificities, they show promise for their biomarker discovery, and for their cancer diagnosis and
treatment. Microfluidic chips will able to improve aptamer-based assays as they operate with
higher throughput and sensitivity, using less reagent volume. Combing microfluidics with
aptamer research will accelerate the rate at which we are able to run assays, potentially allowing
future researchers to more rapidly characterize biological threats such as cancer.

9

2. Details of Key Constraints
2.1 Critiques of Existing Technologies
While other groups have demonstrated on-chip aptamer-based assays, they still do many
preparations steps off-chip. In Lou, et al., the group reported a microfluidic chip capable of
SELEX, but had to perform many analysis steps off-chip, including PCR and binding constant
determination.23 In the Tseng, et al., the group conjugated the aptamers to the magnetic beads
off-chip.2 The conjugation steps required multiple reagents and temperatures for maximum
efficacy, so their choice to perform the steps off-chip made sense. However, when utilizing
normally-closed valves, microfluidic chips can theoretically be detached from pneumatic
controls and be moved into an oven or a fridge to hit different temperature regions. In our
project, we aim to address these portability issues and perform all the steps of the experiment on
the microfluidic chip.
Many of the chips are also limited in their usage. The chip in Lou, et al., is a linear chip with two
inlets. The chips design is simple and cannot be easily upscaled within the current design. Also,
it requires attachment to pneumatic controls to function. The chip presented in Tseng, et al., also
only has four inputs and outputs, limiting the range of experiments and assays that could be
performed on a single chip. In our project, we aim to design a system with many inputs/outputs
that could run multiple assays in parallel. By using multiple micropumps throughout the system,
we aim to design a modular chip which can move fluid to different chambers.
Lastly, some of the chips require complex microfabrication. The chip in Lou, et al., utilizes
microfabricated nickel strips. These strips are difficult to print and fabricate in bulk. Using
simple PDMS structures and an external magnet, we hope to make our chip simple and cheap to
reproduce for potential diagnostic assays.
2.2 Analysis of Key Constraints
For a microfluidic chip to successfully perform aptamer-based assays and compete with existing
well-plate assays, the assay must be completed in a comparable amount of time and get a
comparable or better signal. Additionally, multiple assays need to be conducted in parallel. To
10

complete the assay in a comparable amount of time, the micropumps will need to move fluid
from one chamber to the next in a reasonable amount of time. The microfluidic system should
have a comparable or better signal due to the higher effective concentration at lower volumes. To
run multiple assays in parallel, we plan to design a modular system capable of running multiple
assays on the same chip. Additionally, parallel systems have been utilized in microfluidic
aptamer-assays to increase throughput.25

11

3. Detailed Design Description
3.1 First-Generation Chips
The first-generation chips were designed to test normally-closed valves and flow using normally
closed-valve and micropumps. We designed two valve array chips (Figure 3-1 and 3-2) and one
flow test chip (Figure 3-4). With the valve array chips, we aimed to test the actuation pressures
of the different valves to determine which valve would be most effective with our final design.
The ideal valve would actuate quickly and not tear at high negative pressures.
With the first-generation chips, we intended to make the flow layer 35-µm tall, the control
channel 50 µm tall, and the gap between the two layers 15-µm. These values are standard in
flow-based microfluidics and would not require any difficult fabrication steps.
3.1.1 Actuation Pressure Tests
For actuation tests, a pin connected to a vacuum source is inserted into the flow layer. Increasing
amounts of negative pressure are applied to the flow layer until the normally-closed valves open.
These actuation values are recorded. The tests are repeated across multiple chips to insure
consistency. In Figure 3-1 and 3-2, we would expect the top rows to require less pressure to open
than the bottom rows. The surface area of the valve making contact with the glass is smaller for
the top rows and therefore should require less force to lift off of the surface. Similarly, we would
expect the left columns to require less negative pressure to lift than the right columns.

12

Figure 3-1: An array of normally closed valves with consistent control channel valve widths of 700 µm. Left to
right, the gap between the flow channel increases in 100 µm increments. Top to bottom, the flow channel width
increases in 100 µm increments, and the width of valves increases to maintain 200 µm on the top and bottom of the
flow channel.

Figure 3-2: An array of normally closed valves with control channel valve widths increasing in 200 µm increments.
Left to right, the gap between the flow channel increases in 100 µm increments. Top to bottom, the flow channel
width increases in 100 µm increments, and the width of valves increases to maintain 200 µm on the top and bottom
of the flow channel.

3.1.2 Flow Tests
For flow tests, all three control channels are connected to the vacuum source via pins. For flow,
we intend to use a stepwise scheme to push fluid through the chip (Figure 3-3). Briefly, the fluid
is pulled into the central chamber, held there, then pushed through the other side. This pumping
13

is cyclical and will require multiple sequences to move fluids from one chamber to another. In
this design, the central control channel is square and a similar size to the NCVs.

Figure 3-3: Normally-closed valve flow schematic. The liquid is moved via the following system: 1) fluid reaches
the first NCV, 2) negative pressure is applied over the left NCV and the flow pump to suck liquid into the central
chamber, 3) the left NCV is closed while pressure is maintained over the pump, and 4) pressure is applied over the
right NCV while the pump is relax to push liquid to the right. The sequence is then repeated until the desired amount
of fluid reaches the final chamber.

Figure 3-4: A pump test array. Top to bottom, the flow channel height increases in 100 µm increments, and the
height of valves increases to maintain 200 µm on the top and bottom of the flow channel. The middle control
channel (green) controls a pump, which can create negative pressure over the channel to help pull liquid through the
channel.
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3.2 Second-Generation Chips
From characterization using the first-generation chips, the second-generation chips were
determined to need longer control lines and use circular valves. All channels were 200 µm wide
and gap widths for NCVs were 100 µm. The second-generation chips sought to use circular
micropumps instead of square micropumps. Lastly, the second-generation chips moved towards
a modular design, where fluids from a variety of inputs and outputs could be moved around the
chip and combined.
3.2.1 Changing Flow Channel Heights
Due to results from the first-generation chips, we sought to make our control channels taller. In
short, we had a problem with the micropumps collapsing to bind to the glass, in which case they
could no longer be actuated. This severely limited our ability to pump liquids through the chips.
To counter this issue, we created two flow channel molds with 50-µm and 100-µm tall features,
respectively. At this height, we would not expect the micropumps to collapse.
3.2.2 Changing Control Channel Heights
Results from the 50 µm and 100 µm flow channel chips indicated that the 50 µm control layer
was collapsing on top of the micropump. This limited pumping in a similar way to the last
micropump collapse. To counter this issue, we created a control channel mold with 100 µm tall
features.
3.3 Cartridge-Topper
In preliminary tests, microfluidic chips ran bubbled off of the glass. Because the PDMS
connection to the glass substrate is crucial for the microfluidic channels, bubbling disrupts fluid
flow, allowing fluid to spill out into the surrounding chip. To combat chip bubbling, we designed
a cartridge topper laser-cut from acrylic (Figure 3-5). This cartridge topper contained the
pneumatic valves needed to actuate the chips, which no longer needed to be inserted into the
control channel. The control line holes will likely need to be larger in order to make aligning the
cartridge head and the microfluidic chip easier. Even pressure will be applied to the cartridge
using holding-clamps (McMaster-Carr).
15

Figure 3-5: The cartridge topper schematic. The metal pin in the acrylic cartridge leads to a pneumatic control line,
which can be used to actuate the valves in the microfluidic chip. The cylinder on top of the acrylic cartridge
represents the connection to the clamps, which provide a constant downward pressure.
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4. Expected Results
Our method for accomplishing the detection of a virus references the research collaboration
between the National Tsing Hua University, Taiwan, and the National Cheng Kung University,
Taiwan.2 Beyond their basic detection method and the utilization of normally-closed valves and a
central micropump, our project deviated significantly in the scale of our design.
Our microfluidic chip design aims to operate with less reagent volume and more efficiently at
approximately one third the size of the Taiwanese Research Group’s chip. Additionally, while
Tseng, et al. displayed successful detection of a single virus, H1N1, our group is aiming to
design a microfluidic chip that can scale this model up to the detection of various biomarkers on
a single chip. By making the entire microfluidic chip design smaller, we want to increase the
number of central microchambers, allowing for a higher throughput design that can challenge the
traditional 96 well plate.
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5. Materials and Methods
5.1 Microfluidic Chip Fabrication
The microfluidic chips were designed in AutoCAD (Autodesk). Fineline Imaging created
photolithography masks from the AutoCAD designs. Photolithography was used to create molds,
and soft lithography was used to make PDMS chips from the molds.
5.1.1 Photolithography Process
For photolithography, SU-8 negative resist was utilized to fabricate the control and the flow
layer molds. Table 5-1 details specific conditions used at each step to obtain varying mold
heights. For the flow mold, the silicon wafers were treated with HDMS. SU-8 was placed on the
wafer, and the flow mold was spin coated. The wafer was soft baked for 90s at 115°. The mold
was exposed to the photolithography mask and UV light. The layer was developed. Lastly, the
mold was hard baked starting at 65° and ramping up to 190° over fifteen hours.
For the control mold, SU-8 2015 was spun onto the silicon wafer. The mold was then baked for
60 s at 65°, 180 s at 95°. The mold was exposed to the photolithography mask and UV light, then
baked for 60 s at 65°, 180 s at 95°. The mold was then developed with SU-8 and rinsed and
dried. Lastly, the mold was hard baked starting at 65° and ramping up to 160° over two hours.
Table 5-1: Photolithography conditions to create mold heights.
Mold Height
[µm]

Spin Speed
[rpm]

Spin Time [s]

Exposure Time
[s]

Development
Time [min]

35

1800

60

30

1

50

3000

30

13

5

100

1500

30

18

8

200

625

30

30

15
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5.1.2 Soft Lithography Process
In soft lithography, the control and flow layer molds are used to form two corresponding layers
of PDMS. These layers are then bound together to create the final microfluidic chips. For the
control layer we begin by mixing a 5:1 ratio of PDMS Part A to the PDMS curing agent Part B.
This combination is then mixed for 2 minutes in a mixer (Thinky). The resulting PDMS is then
poured over the control mold and degassed in a chamber. After degassing the mold is then baked
at 80 degrees for 30 minutes.
For the flow layer PDMS is made with a 20:1 ratio of Part A to Part B. PDMS is spin coated over
the mold at various speeds depending on the height of the mold features (Table 5-2). The PDMS
layer is then baked for 30 minutes at 80 degrees.
Table 5-2: Conditions tested to obtain various control and flow channel heights.
Mold Height [µm]

Spin Speed [rpm]

Spin Time [s]

35

2000

30

50

1400

30

100

700

30

200

350

30

After baking, the PDMS chips are then peeled from the molds and cut into individual chips. The
newly cut control layers are hole punched with a 700 µm hole and then placed upon their
corresponding flow layers and baked in the oven at 80 degrees for 24 hours. After baking,
inlet/outlet holes are cut for the flow layer with 2 mm holes. The chips are then plated on glass
and tested.
5.2 Microfluidic Testing Protocol
To begin, the vacuum control pins are attached to the corresponding flow inputs. The valves are
actuated using -20 PSI to ensure actuation when the fluid is later flowed through the system.
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Then, the reagents are added into the various flow inputs using pipettes or syringes. Lastly, the
valves are actuated to do flow or mixing automatically using a control box and -20 PSI air
pressure (Elveflow). In automated tests like flow and mixing, the valves were actuated at 200 ms
intervals.
5.3 Flow Rate Calculations
Flow rate calculations are performed in two ways: an initial flow rate calculation and a longer,
average flow rate calculation.
For the initial flow rate calculation, the time for the fluid to reach the output from the input while
the chip is pumping is recorded. The total area of the microfluidic chip traveled by the liquid is
determined by calculating the area in the AutoCAD designs. This area is multiplied by the flow
channel height to determine the volume traveled by the liquid. Then the volume is divided by the
time it took to flow through the chip to determine flow rate, which is converted into the most
relevant units, either µL/s or nL/s.
For the average flow rate calculation, the volume of the input reservoir is calculated. Input holes
were punched using a 2 mm hole puncher. The area of the circle is multiplied by the theoretical
height of the chip, 2 mm. This yields a volume of 6.3 µL. Once pumping begins, the time it takes
to empty the reservoir is determined. The volume is divided by the time to determine flow rate,
which is converted to the most relevant units, either µL/s or nL/s.
5.4 Cartridge Topper
The cartridge toppers and base were designed in AutoCAD (Autodesk). The topper designs were
then cut into ⅛ inch acrylic and the base was cut into ⅜ inch acrylic using an Epilog Zing24
60W laser cutter (Epilog Laser). Four holding-clamps (McMaster-Carr) were fixed to the base
using bolts, washers, and screws. The height of the toppers was adjusted using washers and bolts
to snuggly fit over the microfluidic device.
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6. Results
6.1 Normally-Closed Valve Characterization
To optimize our NCVs, we tested different NCVs with varying multiple dimensions of the valves
to determine how these changes impacted the actuation pressure. Specifically, we tested how
changes in flow channel width, valve gap width, and control channel valve width affected
actuation pressure (Figure 6-1).

Figure 6-1: The three parameters varied in actuation pressure tests. Channel widths varied between 200 µm and 500
µm, gap widths 200 µm and 500 µm, and valve widths varied between 400 µm and 1000 µm.

Various flow channel widths starting from 200 µm in diameter and increasing by 100 µm up to
500 µm diameter were used to determine which sizes allowed the valves to actuate with the least
amount of pressure. Channel width is the width of the channel before and after the normally
closed valve. As seen in Figure 6-2, it was determined that varying channel width did not
significantly change the pressure required to actuate the valves.
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Figure 6-2: Negative pressure of actuation for NCVs with increasing channel widths.

The next test was conducted to determine the impact of gap width on opening the normally
closed valves. Gap width is the size of the closed portion of the control channel in the normally
closed valve. Similar to channel width, gap widths were varied starting from 200 µm in diameter
and increasing by 100 µm up to a 500 µm diameter. It was determined that as gap width
increased, the negative pressure required to open the valve also increased. As seen in Figure 6-3,
this indicates gap width has a positive correlation with opening the NCVs. As gap width
increases, the normally closed valve has a greater surface area contact with the glass, making the
valves more difficult to open.

22

Figure 6-3: Negative pressure of actuation for NCVs with increasing gap widths.

The next test was conducted to determine the impact of valve width on opening the normally
closed valves. Valve width is the size of the vacuum chamber in the normally closed valve.
Unlike channel and gap width, valve widths were varied starting from 400 µm in diameter and
increasing in 200 µm steps up to a 1000 µm diameter. It was determined that as valve width
increased, the negative pressure required to open the valve also decreased. As seen in Figure 6-4,
this indicates gap width has a negative correlation with opening the NCVs. As valve width
increases, the normally closed valve has a greater region of actuation, making the valves easier to
open.
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Figure 6-4: Negative pressure of actuation for NCVs with increasing valve widths.

The final variable changed in optimization of the normally closed valves was testing different
geometric shapes for the valves. In this experiment we test rectangular valves in the firstgeneration chips versus circular valves used in the second-generation chips. It was determined
that square valves require a greater amount of negative pressure to actuate them. Across 25 trials,
square valves opened at an average of -10.75 PSI, whereas the circular valves opened at an
average of -4.36 PSI. Circular valves required less than half the amount of pressure to actuate
and open the valves. These tests indicate that the optimum design for the NCVs are circular
valves with a gap width of 200 µm.
6.2 Flow Demonstration with Oil
Flow was demonstrated on the second-generation chips with varying flow channel and control
channel heights. Flow could not be generated on the chips with 50 µm tall flow and 50 µm tall
control channels. The micropumps were collapsed and were insufficient to move oil beyond its
natural flow due to its low surface energy. Flow was demonstrated on chips with 100 µm tall
flow and 50 µm and 100 µm tall control channels.
6.2.1 Oil Flow on Chips with 100 µm Tall Flow Channels and 50 µm Tall Control Channels
Basic flow was demonstrated on the three-input chips with 100 µm tall flow channels from the
second generation. First, 6.3 µL of dyed oil was placed in one input, and the sequential pumping
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sequence was used to pull the dye into the central chamber with the valves and micropump
actuating every 200 ms (Figure 6-5). The dye was then pumped from the central chamber into
another input valve. Moving the liquid from one input to the other took ~5 minutes at a rate of 2
nL/s.

Figure 6-5: Sequential flow through a three-input 100 µm tall flow and 50 µm tall control channels chip. A) The
fluid is inserted into an input and naturally flows to the first NCV, B) using the central micropump, liquid is pulled
into the central micropump and pushed towards the upper-left input, and C) continuing to use the micropump, fluid
is moved to the upper-right input.

While flow was demonstrated, it was quite slow. The flow seems to be slow due to the collapse
of the micropump (Figure 6-6). The control layer seems to be collapsing into the membrane.
These fuses likely occur due to sagging during fabrication, resulting in the two layers being
baked together. When actuated, these collapsed valves will only actuate around the edges (Figure
6-6B). While this provides some pumping power, it explains the long pumping times
experienced.
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Figure 6-6: Actuation of the 100 µm tall flow channel and 50 µm tall control channel micropumps. The collapse is
shown in the center of the pump by the circle. A) The pump in the resting state with no pressure applied, and B) the
pump with pressure applied. The thin darkened ring pointed at by the arrow is the area of the valve we see deflect.

6.2.2 Oil Flow on Chips with 100 µm Tall Flow Channels and 100 µm Tall Control Channels
In initial tests with the 100 µm tall flow and 100 µm tall control channels, the standard -20 PSI
was not sufficient to consistently actuate the valves or the micropump. The vacuum pressure was
adjusted up to -35 PSI, and the valves consistently actuated.
Flow from the input to the output through the micropump using oil was successful (Figure 6-7).
Again, 6.3 µL of dyed oil was placed in one input. The valves were actuated every 200 ms. The
flow rate vastly improved. It took 4 seconds to move the oil from the input to the output at a flow
rate of 150 nL/s, and 1 minute to empty the input channel at a flow rate of 1.05 µL/s. The
discrepancy in flow rate is probably due to more fluid being drawn into the pump over time. The
micropump showed no indication of collapse. The circle shown in the center of the micropump
was the center membrane touching the top of the control channel when actuated (Figure 6-7C).
This provided significantly more negative pressure into the micropump and is likely the cause of
the increased pumping rate.
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Figure 6-7: Flow through the 100 µm tall flow and 100 µm tall control channel chip with oil. A) The fluid is
inserted into an input, B) using the central micropump, liquid is pulled into the central micropump and pushed
towards the lower-right output, and C) continuing to use the micropump, fluid is moved to the upper-right input.

6.3 Mixing Demonstration Using Oil
After flow was demonstrated, differently colored oils were inserted into another input and pulled
into the micropump to be mixed.
6.3.1 Mixing Oils on Chips with 100 µm Tall Flow Channels and 50 µm Tall Control Channels
To show mixing, a blue oil was introduced into the third input of a three-input chip (Figure 6-8).
The oil was brought into the central micropump using a sequential flow with 200 ms intervals
between actuations. The dyes diffused minimally into each other where they met but did not truly
mix together. Roughly equal amounts of the liquids did fill the chamber, which is promising for
mixing and preparation steps for an aptamer-based assay.
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Figure 6-8: Sequential mixing in a three-input chip. A) The fluid is inserted into the third input and naturally flows
to the first NCV, B) using the central micropump, liquid is pulled into the central micropump, and C) the pump
continues running until roughly equal amounts of the liquids are present.

6.3.2 Mixing Oils on Chips with 100 µm Tall Flow Channels and 100 µm Tall Control Channels
Similar to flow, mixing was vastly improved on the chips with 100 µm tall flow and 100 µm tall
control channels. Due to the greater pumping efficiency, it was much more difficult to fill up the
central micropump without having backflow down the input lane. The micropump was filled as
much as possible to start (Figure 6-9A). Next, blue oil was pulled in from the upper right input
(Figure 6-9B). The two colored mixed until the blue dye ran out (Figure 6-9C). The two oils
successfully mixed together, despite the difficulties completely filling up the micropump
completely. The yellow dye running up into the input at the start was due to a previous
unsuccessful attempt to bring both liquids into the micropumps at the same time.
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Figure 6-9: Sequential mixing in a 100 µm tall flow and 100 µm tall control channel chip with oil. A) The fluid is
inserted into the third input, B) using the central micropump, liquid is pulled into the central micropump, and C) the
pump continues to mix the liquids until the two colors are mixed.

6.4 Modular Chip Demonstration Using Oil
Once flow and mixing had been demonstrated using our micropumps, we aimed to show
modular flow using our modular chip design. To run an aptamer-based assay on our microfluidic
device, fluid will need to be moved from one section of the chip to another. For the
demonstration, we moved fluid from two inputs across two micropumps (Figure 6-10). Then, we
pumped one of the liquids into the other to demonstration mixing. During the mixing, the liquids
did not truly mix, again; however, equal amounts of both liquids seemed to be present in the final
chamber. Moving the fluids across two micropumps took ~15 minutes for a flow rate of 20 nL/s
and pumping one fluid into the other took ~5 minutes. The difference in the flow rate between
the 100 µm tall flow and 50 µm tall control channel chip and this modular chip is likely due to
the second pump on each side.
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Figure 6-10: Sequential mixing in a three-input chip. A) The fluid is inserted into the third input and naturally flows
to the first NCV, B) using the central micropump, liquid is pulled into the central micropump, and C) the pump
continues running until roughly equal amounts of the liquids are present.

6.5 Mixing and Flow Using Water-Based Solutions
After flow and mixing were demonstrated using oil, we sought to use water-based solutions on
the chips. In attempts with chips with 100 µm tall flow and 50 µm tall control channels, the
negative pressure from the collapsed micropumps was insufficient to overcome the repelling
interaction between PDMS and water. Using 100 µm tall flow and 100 µm tall control channels
and the higher vacuum pressure, we were able to demonstrate water flow and mixing.
6.5.1 Water Flow on Chips with 100 µm Tall Flow Channels and 100 µm Tall Control Channels
The micropump pulled water through the chip using actuation 200 ms increments (Figure 6-11).
Water was moved from the bottom right input to the central micropump to the upper left output.
An oil-based dye was used, and it did not initially travel with the water. The water movement
can be seen in the bubble and reflection in Figure 6-11B and in the reflection in Figure 6-11C.
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Similar to flow with oil, the water took 5 seconds to reach the upper left output at a flow rate of
1.32 µL/s and ~20 seconds to empty the input well at a flow rate of 3.14 µL/s. The discrepancy
in flow rates again is likely due to the pump fully filling up.

Figure 6-11: Flow through the 100 µm tall flow channel and 100 µm tall control channel micropump using water.
A) Water with a yellow oil-based dye was inserted into the input, B) the water was pulled into the central
micropump, and C) the water was pumped to the upper left output.

6.5.2 Mixing Water-Based Solutions on Chips with 100 µm Tall Flow Channels and 100 µm Tall
Control Channels
We demonstrated mixing using water-based solutions (Figure 6-12). Given the oil-based dyes,
the mixing was difficult to visualize. The change of volume in the chamber indicated by the
changes in the bubble volume indicated the blue water was pulled into the micropump.
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Figure 6-12: Sequential mixing in a 100 µm tall flow and 100 µm tall control channel chip with water. A) A blue
oil-based dye and water was inserted, B) the blue water was pulled into the micropump, C) the bubbles dissipated
indicating the blue-dye is brought into the chamber.

6.6 Actuation Using the Cartridge-Topper
The valve and micropump actuation were demonstrated using the cartridge topper (data not
shown). The cartridge-topper was set-up and visualized under the microscope (Figure 6-13). To
fabricate chips to be compatible with the cartridge topper, 2.5 mm holes are cut for the control
lanes. This makes them easier to align with the holes. Ideally, the chip would be larger than all
the holes, so fluids could be inserted into the holes of the cartridge. Figure 6-13B highlights how
the large control and input holes can obscure the features underneath. The acrylic can also be
easily scratched or coated in epoxy, making imaging difficult.
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Figure 6-13: The cartridge topper with a microfluidic chip. A) the system set-up under the microscope, and B) a
microscopic image of the chip.
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7. Discussion
7.1 Normally-Closed Valve Characterization
Normally-closed valves are essential to our design because they allow the microfluidic chip to be
transported to different temperature areas. Since we aim to do all the assay steps on chip, we will
need to incubate different reactions at different temperatures. Normally-closed valves ensure the
fluids stay in their chamber while the chip is disconnected from pneumatic controls.
In the characterization of our normally-closed valves, we established two relationships between
the dimensions of the valve and the actuation pressure needed to open the valve. First, we found
increases in channel width within 200-500 µm did not lead to increases in the pressure required
for valve actuation. As channel width increased in our designs, the width of the valve also
increased. Therefore, the surface area of the valve relative to the control lane stayed constant.
Second, we found that increasing the gap width between the flow layers lead to a linear increase
in actuation pressure from 200-500 µm. As gap width increases, the relative surface area of the
valve to the control lane increased. An increase in the surface area of the valve relative to the
control lane is expected to increase actuation pressure, so our results agreed with results we saw
in literature.
Third, we found that increasing the width of the valve lead to a linear decrease in actuation
pressure from 200 µm to 1000 µm. Increasing valve width provides a greater area in the control
channel to apply vacuum pressure, essentially making the valves easier to open due to a greater
net force.
Lastly, we compared rectangular and circular valves. At the same gap width, circular valves
actuated at approximately half the negative pressure of rectangular valves. Rectangular valves
suffered from bursting at higher pressures, likely due to corners ripping. Circular valves mitigate
this issue. Across roughly 25 tests with circular valves, we only observed a valve bursting once.
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7.2 Characterization of the Microfluidic Platform
For our microfluidic platform to successfully run aptamer-based assays, it needs to demonstrate
flow, mixing, and modular movement across the chip.
To be capable of running an aptamer-based assay, our chip needs to move liquids from one
chamber to another and mix two liquids together. We initially tested flow using oils because the
low surface energy of oils means they will readily move through PDMS. Using oil, we
successfully demonstrated flow and mixing in microfluidic chips with 100 µm tall flow and 50
µm tall control channels and 100 µm tall flow and 100 µm tall control channels. Moving from 50
to 100 µm tall control channels, we increased our vacuum and saw a tremendous increased in the
negative pressure applied by our micropump. Flow from one input to another was reduced from
~5 minutes to ~5 seconds with oils. Initially, the chip achieved a flow rate of 150 nL/s. It took 1
minute to empty the input reservoir at a flow rate of 1.05 µL/s. The discrepancy in flow rate is
probably due to the pump not completely filling during the initial calculation. Another source of
error could be the estimated 2 mm height of the chip. We occasionally saw chips that were
different heights on the molds due to a sloped surface during baking. Using the 100 µm tall flow
and 50 µm tall control chips, we were able to bring equal volumes of dye into a micropump but
were unable to mix them. Using the 100 µm tall flow and 100 µm tall control chips, we were
able to successfully mix the oils in the micropump. Due to the greater negative pressure
generated by the micropump, we had difficulty moving equal volumes into the chip.
After the oil-based flow and mixing, we moved to water-based solutions. Aptamer-based assays
are water-based, so our chips need to be compatible with them. Additionally, we sought to avoid
treating the PDMS because it could add reactive chemical groups and sought to not use
detergents to lower the surface energy of water because they could potentially interfere with the
reagents in the aptamer-based assay. Attempts to use water on the 100 µm tall flow 50 µm tall
control chips proved unsuccessful. Due to the collapse in the micropump, the micropump could
not provide adequate pressure to overcome the hydrophobic/hydrophilic interactions between the
PDMS and water. Using the 100 µm tall flow and 100 µm tall control chips, we were able to
show flow from one input to an output in 5 seconds at a flow rate of 1.32 µL/s and took ~20
seconds at a flow rate of 3.14 µL/s to empty the reservoir. This water flow rate is notably higher
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than the oil flow rate. The oil tests were performed on a micropump with a radius of 1250 µm
and the water tests were performed on a micropump with a radius of 750 µm. Further work needs
to be done to determine the flow rate differences between these two pumps (discussed in section
7.4).
Lastly, we demonstrated movement of liquids across our 3x2 micropump chip. The modular chip
provides a powerful platform for running assays. Single or multiple assays can be run on the chip
by segmenting the different reactions in different micropumps. The modular design could easily
be upscaled to include more inputs/outputs and micropumps. The modular design has the
potential to provide high throughput analysis for diseases or biochemical assays.
7.3 Cartridge-Topper
The cartridge-topper provides a means to rapidly connect a complex microfluidic chip to
pneumatic controls. Instead of inserting multiple vacuum pins, the cartridge is simply aligned
over the chip and pressure is applied to the cartridge to hold it in place and prevent liquids from
flowing out of the reservoirs on the chips. If multiple assays are being sequentially run, the
cartridge-topper provides a rapid means to hook-up a new chip. The cartridge-topper also
improves our ability to make our microfluidic chip portable, as it eliminates the need to
disconnect and reconnect pneumatic lines when moving the chip and prevents the chip from
peeling from the glass during disconnections..
Using the cartridge-topper, we successfully demonstrated actuation of valves and the
micropump. Given this successful actuation, the cartridge topper could be used to perform future
tests on our microfluidic devices.
7.4 Future Work
Several experiments still need to be done to characterize and improve our chips. For all of our
flow experiments, we used 200 ms valve actuation steps. Further work could be done to
characterize flow speeds at other frequencies. Additionally, we saw an increase in flow speed
and micropump efficiency when we switched to a vacuum capable of providing a greater
negative pressure. Further work could be done to test a range of vacuum pressures between -20
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to -50 PSI to determine the optimal vacuum pressure. As noted in our results, at the increased
vacuum pressure, we had difficulty filling up a micropump, which would be important for an
aptamer-based assay. Likely, the pressure needs to be decreased for these steps. Lastly, we tested
micropumps of different sizes, including 750, 1000, and 1250 µm radius, and further work could
be done to determine the differences in flow rate between these micropumps.
Lastly, we need to perform a proof-of-concept aptamer-based assay on our microfluidic device.
We propose performing an assay to target nucleolin, a protein involved in the synthesis and
maturation of ribosomes. An aptamer has been previously been isolated for nucleolin, as
described in Guo, et al..26 Aptamers would be ordered with the known sequence and with a
amide group on one tail. These aptamers would be put in a compatible buffer and inputted into
the 3x2 micropump chip. Carboxylic nanoparticles, likely 500 nm - 1 µm in diameter, would be
combined with EDC, a carboiimide crosslinker (ThermoFisher). The nanoparticles and aptamers
would be brought into a single chamber and incubated for 2 hours at 2° C. The conjugated
aptamer-nanoparticles would then be held in place using a magnet and wash to remove any
excess aptamers. Next, nucleolin would be introduced into the system and be allowed to bind to
the aptamers. After a sufficient incubation, the excess nucleolin would be rinsed away. Next,
another aptamer or a nucleolin antibody would be added. Either would likely be conjugated to
horseradish peroxidase to catalyze a color-based reaction, which would indicate the amount of
nucleolin bound.
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8. Engineering Standards and Realistic Constraints
8.1 Ethical
Our microfluidic device has the potential to positively impact society by providing a fast, simple
means to run diagnostic assays. Patients receiving accurate medical information lets them make
informed decisions about their medical treatment, leading to a net-positive in society. According
to utilitarian ethics, maximizing societal utility and individual well-being is ethically sound. We
believe our chip has the potentially to positively impact society though its diagnostic potential.
8.2 Science, Technology, and Society and Civic Engagement
The microfluidic devices presented here will positively impact the science community by
providing an easy-to-use assay system. This system can remove some tedious steps of traditional
microplate assays. Once assays are developed on this system, we foresee that it could be easily
adapted into medical environments for the screening of a wide variety of diseases.
When assays are developed on the chip, they will need to be evaluated by the FDA for their
efficacy before they are sold or distributed to medical professionals. The assays would need to
effectively determine if the target analytes were present, and medical professionals would need
to understand what the presence of the analytes indicated about the patients’ health.
8.3 Economic
Our microfluidic device is cheap to manufacture and aptamer-based assays prevent a cheaper
alternative to traditional antibody-based assays. Our device is simple and make of PDMS, which
is a cheaper polymer. The cartridge topper is made of acrylic, another readily available and
cheap material, and several inexpensive mechanical parts. Aptamer-based assays are cheaper
than antibody-based assays because aptamers are much cheaper to produce due to advances in
DNA synthesis technologies. We expect that our product would be at a competitive price in the
device market.
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8.4 Health and Safety
Microfluidic chips present minimal health risks and have the potential to provide diagnostic
benefits to patients. Operating the chips is straightforward and safe. Diagnostic platforms allow
screening of a variety of diseases and conditions to provide an overall benefit to public health.
Early disease detection can lead to higher survival rates and give patients more options when
treating diseases. Overall, we feel the impact of our microfluidic devices will be positive.
8.5 Manufacturability and Usability
The microfluidic chips presented here are fairly easy to fabricate. The molds made from
photolithography can be reused to make many chips as long as they are handled with care.
PDMS is a simple polymer to mix, pour, and work with. The most technically challenging part of
the fabrication is punching the control channel holes and aligning the two layers together. Using
manufacturing robots, this process could be easily automated to produce large amounts of our
chips.
The cartridge topper makes the chips easy to use. The chips merely have to be aligned under the
topper, eliminating the tedious steps of connecting multiple pneumatic control lines. Once
aligned and pressure is applied on the cartridge topper, fluids can be pipetted into the holes on
the cartridge topper. With the modular aspects of the device, a wide variety of assays could be
run with our microfluidic design. Future designs could incorporate more inputs/outputs to allow
for even greater usability and control.
8.6 Sustainability and Environmental Impact
The microfluidic chips in this project have the potential to increase the sustainability of
diagnostic assays by utilizing less resources and having the potential to be reusable. The assays
are smaller than well-plates traditionally used for diagnostics, utilizing less resources per test.
PDMS is an elastic material and could theoretically be used for multiple runs of a single test,
eliminating the need to use a new chip every time. If an efficient cleaning method is developed,
the chips could be used for multiple tests.
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The chips lessen the environmental impact of traditional assays by using less reagent volume
than traditional diagnostic assays. Working on the microscale requires less volume, meaning less
buffers, aptamers, signaling elements, etc. need to be used. PDMS is also an inert polymer and
does not present any toxic effects. Utilizing “green chemistry” in the assay could also further
lessen the environmental effects of running the assays.
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